These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36609055)

  • 21. Pharmacists' chronic disease management in chronic obstructive pulmonary disease: Effect on health services utilization.
    Makhinova T; Johnson JA; Minhas-Sandhu JK; Necyk C; Bhutani M; Eurich DT
    J Manag Care Spec Pharm; 2023 Jun; 29(6):671-679. PubMed ID: 37276041
    [No Abstract]   [Full Text] [Related]  

  • 22. Epidemiology, severity, and treatment of chronic obstructive pulmonary disease in the United Kingdom by GOLD 2013.
    Raluy-Callado M; Lambrelli D; MacLachlan S; Khalid JM
    Int J Chron Obstruct Pulmon Dis; 2015; 10():925-37. PubMed ID: 25999708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacist-led intervention study to improve drug therapy in asthma and COPD patients.
    Ottenbros S; Teichert M; de Groot R; Griens F; Sodihardjo F; Wensing M; de Gier JJ
    Int J Clin Pharm; 2014 Apr; 36(2):336-44. PubMed ID: 24293335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Guideline for the management of chronic obstructive pulmonary disease (COPD): 2004 revision.
    Bateman ED; Feldman C; O'Brien J; Plit M; Joubert JR;
    S Afr Med J; 2004 Jul; 94(7 Pt 2):559-75. PubMed ID: 15283307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inverse relationship between nonadherence to original GOLD treatment guidelines and exacerbations of COPD.
    Foda HD; Brehm A; Goldsteen K; Edelman NH
    Int J Chron Obstruct Pulmon Dis; 2017; 12():209-214. PubMed ID: 28123293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Community Assessment of COPD Health Care (COACH) study: a clinical audit on primary care performance variability in COPD care.
    Abad-Arranz M; Moran-Rodríguez A; Mascarós Balaguer E; Quintana Velasco C; Abad Polo L; Núñez Palomo S; Gonzálvez Rey J; Fernández Vargas AM; Hidalgo Requena A; Helguera Quevedo JM; García Pardo M; Lopez-Campos JL;
    BMC Med Res Methodol; 2018 Jul; 18(1):68. PubMed ID: 29970023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Missed diagnosis or misdiagnosis: how often do hospitalised patients with a diagnosis of chronic obstructive pulmonary disease have spirometry that supports the diagnosis?
    Habteslassie D; Khorramnia S; Muruganandan S; Romeo N; See K; Hannan LM
    Intern Med J; 2023 Apr; 53(4):510-516. PubMed ID: 34719093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of a Pharmacist-driven Spirometry Clinic Service within a Community Family Health Center: A 5-year Retrospective Review.
    Cawley MJ; Warning WJ
    J Res Pharm Pract; 2018; 7(2):88-94. PubMed ID: 30050962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of the new GOLD COPD staging system to a US primary care cohort, with comparison to physician and patient impressions of severity.
    Mapel DW; Dalal AA; Johnson PT; Becker LK; Hunter AG
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1477-86. PubMed ID: 26251587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of primary care in early diagnosis and effective management of COPD.
    Bellamy D; Smith J
    Int J Clin Pract; 2007 Aug; 61(8):1380-9. PubMed ID: 17627713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hospitalised exacerbations of chronic obstructive pulmonary disease: adherence to guideline recommendations in an Australian teaching hospital.
    Sha J; Worsnop CJ; Leaver BA; Vagias C; Kinsella P; Rahman MA; McDonald CF
    Intern Med J; 2020 Apr; 50(4):453-459. PubMed ID: 31157943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spirometry is underused in the diagnosis and monitoring of patients with chronic obstructive pulmonary disease (COPD).
    Yu WC; Fu SN; Tai EL; Yeung YC; Kwong KC; Chang Y; Tam CM; Yiu YK
    Int J Chron Obstruct Pulmon Dis; 2013; 8():389-95. PubMed ID: 24009418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implementing pharmacist-led diabetic digital retina scan services at a federally qualified health center.
    Mize K; Sawkin M; Melton BL
    J Am Pharm Assoc (2003); 2024; 64(1):154-158. PubMed ID: 37769848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COPD-X Australian and New Zealand guidelines for the diagnosis and management of chronic obstructive pulmonary disease: 2017 update.
    Yang IA; Brown JL; George J; Jenkins S; McDonald CF; McDonald VM; Phillips K; Smith BJ; Zwar NA; Dabscheck E
    Med J Aust; 2017 Nov; 207(10):436-442. PubMed ID: 29129177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of the implementation of a pharmacist-driven chronic obstructive pulmonary disease exacerbation orderset in an inpatient setting.
    Petite SE; Murphy JA
    Am J Health Syst Pharm; 2020 Jul; 77(14):1128-1134. PubMed ID: 32470115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discriminative Accuracy of the CAPTURE Tool for Identifying Chronic Obstructive Pulmonary Disease in US Primary Care Settings.
    Martinez FJ; Han MK; Lopez C; Murray S; Mannino D; Anderson S; Brown R; Dolor R; Elder N; Joo M; Khan I; Knox LM; Meldrum C; Peters E; Spino C; Tapp H; Thomashow B; Zittleman L; Make B; Yawn BP;
    JAMA; 2023 Feb; 329(6):490-501. PubMed ID: 36786790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of pharmacist-led interventions on medication adherence and inhalation technique in adult patients with asthma or COPD: A systematic review and meta-analysis.
    Jia X; Zhou S; Luo D; Zhao X; Zhou Y; Cui YM
    J Clin Pharm Ther; 2020 Oct; 45(5):904-917. PubMed ID: 32107837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COPD management costs according to the frequency of COPD exacerbations in UK primary care.
    Punekar YS; Shukla A; Müllerova H
    Int J Chron Obstruct Pulmon Dis; 2014; 9():65-73. PubMed ID: 24426781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Consistency of chronic obstructive pulmonary disease regimens for patients visiting community pharmacies with the Global Initiative for Chronic Obstructive Lung Disease recommendations.
    Prosser TR; Bollmeier SG
    J Am Pharm Assoc (2003); 2021; 61(3):299-307. PubMed ID: 33549503
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.